Media Pack
News

Current Edition

Volume 7 issue 1

Upcoming Events

 
 

Advertisement

 
 
news

Sanofi, GSK say COVID vaccine works as booster, but delay key study results

Sanofi and GSK expected to have definitive results for their long-delayed coronavirus vaccine by now, having redesigned their shot after an initial formulation disapp...
16 December 2021 news booster | coronavirus vaccine
Continue Reading →
news

Pfizer again asks FDA to authorize COVID-19 boosters for all adults

Agency advisers had opposed a broad booster dose clearance in September, leading the FDA to limit use to older adults and those at high risk of COVID-19. Pfizer and ...
15 November 2021 news adults | BioNTech
Continue Reading →
news

J&J foresees end to not-for-profit sales of coronavirus vaccine

J&J has recorded far fewer sales of its coronavirus vaccine than competitors Pfizer and Moderna, partly due to its not-for-profit pricing but also to a series of ...
22 October 2021 news coronavirus vaccine | J&J
Continue Reading →
news

CureVac scraps its first COVID-19 vaccine and pivots to a second

After months sticking with its coronavirus vaccine, CureVac has finally given up. CureVac executives had long argued the shot could still play a role in fighting COV...
15 October 2021 news aged 18-60 | Biotech
Continue Reading →
news

J&J asks FDA to clear booster dose of its coronavirus vaccine

For the past several months, one of the many questions hanging over the booster debate has ben what do with people who got J&J's shot. The company's application, ...
8 October 2021 news Centers of Disease Control and Prevention | coronavirus vaccine
Continue Reading →
news

CureVac scales back mRNA manufacturing for coronavirus vaccine

While not acknowledged directly, the "corresponding changes in demand" could also stem from disappointing clinical trial results CureVac released for its vaccine in m...
17 September 2021 news coronavirus vaccine | CureVac
Continue Reading →
news

FDA grants full approval to Pfizer, BioNTech’s coronavirus vaccine

The Food and Drug Administration on Monday granted full approval to Pfizer and BioNTech's coronavirus vaccine, a long-awaited decision that government officials hope ...
27 August 2021 news BioNTech | coronavirus vaccine
Continue Reading →
 
 
IBI-white.png

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Facebook Linkedin
Bio Pharmaceutical Media © 2024, All Rights Reserved – Powered by Teksyte